FNDC4 and obesity due to melanocortin 4 receptor deficiency: The potential beneficial effects of FNDC4 on COVID-19 outcomes include anti-obesity [2, 7, 67] and anti-inflammatory [2, 68] activities, such as inhibiting M1 polarization of macrophages and pro-inflammatory cytokine production in AT.